Skip to main content

Park Ha Biological Technology Co., Ltd.

corporate_fare Company Profile

Park Ha Biological Technology Co., Ltd.

BYAH·NASDAQ·Life Sciences·CIK 0001986247

Park Ha develops and sells skincare products, primarily through its private label brand "Park Ha," which focuses on solutions for problematic skin. The company was established in 2016, with its first store opening in 2017. Park Ha operates through direct sales of skincare products and franchise alliances promotions. As of October 31, 2025, the company had five stores directly operated by Park Ha Jiangsu. Additionally, as of October 31, 2025, 2024, and 2023, the company had 22, 45, and 38 franchisees in China, respectively. Of these, 22, 43, and 36 franchisees operated under the "Park Ha" store name as of the same dates. As of October 31, 2025, 2024, and 2023, 0, 2, and 2 franchisees operated under the "Geni" brand name. Park Ha's PRC subsidiaries specialize in providing skincare and cosmetic products under the "Park Ha" brand in China. These subsidiaries develop proprietary beauty products and offer complimentary after-sales beauty services in physical stores. Park Ha Jiangsu operates seven physical stores and serves as the research and development center for skincare products, focusing on sensitive skin. Xinzhan manages marketing, promotions, and the franchising business. Park Ha Jiangsu also provides training to franchisee staff. Both directly-operated stores and franchisees offer a "light beauty experience," a quick complimentary after-sales beauty service, to demonstrate product usage. The company's revenues primarily come from product sales and franchise fees. As of October 31, 2025, the 22 franchisees are located in Jiangsu Province (16), Shandong Province (2), Liaoning Province (1), Shanxi Province (1), Heilongjiang Province (1), and Hebei Province (1).

Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) is a publicly traded company in the Life Sciences sector. Wiseek monitors BYAH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Park Ha Biological Prices $2.0M Registered Direct Offering at $1.50/Share, Significant Dilution
  • Park Ha Biotech Prices $2M Offering at 17% Discount, Signaling Urgent Capital Need
  • Park Ha Biological Forms Strategic AI & Wellness Partnership with Star Plus Legend Subsidiary
  • Park Ha Biological Opts Out of Key Nasdaq Governance Rules, Weakening Shareholder Protections
  • Park Ha Biological Reports $24.36M Net Loss, Cites Massive Share-Based Compensation & Internal Control Weakness

Financial Snapshot

Fiscal year ended October 31, 2025
Revenue
$2.52M
Net Income
-$24.36M
Diluted EPS
-$41.38
Op. Cash Flow
$85.85K
Free Cash Flow
-$2.97K
Gross Profit
$2.38M
Operating Income
-$24.15M
Cash & Equivalents
$3.79M
Debt / Equity
0.00×
Net Margin
-9.65×
Shares Outstanding
588.87K sh
Source: 20-F · filed 2026-05-15 · accession 0001213900-26-057152

Insider Transactions

BYAH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →
$1.39 -0.08% today
52-week range · as of 2026-06-12 $0.9301 – $2074.5
Market cap
$4.73M
Volume
105.1M (20.1× avg)
3-mo avg 5.2M
Live data · 2026-06-14 02:05 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BYAH - Latest Insights

BYAH
Jun 12, 2026, 2:55 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.74
Real-time Price: $1.39 info
Change: -$0.3507 (-20%) info
Market Cap: $4.734M info
BYAH
Jun 12, 2026, 2:54 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.81
Real-time Price: $1.39 info
Change: -$0.415 (-23%) info
Market Cap: $4.734M info
BYAH
Jun 12, 2026, 8:30 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.83
Real-time Price: $1.39 info
Change: -$1.44 (-51%) info
Market Cap: $4.734M info
BYAH
Jun 04, 2026, 8:47 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.24
Real-time Price: $1.39 info
Change: +$0.150 (+12%) info
Market Cap: $4.734M info
BYAH
May 15, 2026, 8:02 AM EDT
Filing Type: 20-F/A
Importance Score:
9
Price at Filing: $1.50
Real-time Price: $1.39 info
Change: -$0.110 (-7%) info
Market Cap: $4.734M info
BYAH
Apr 28, 2026, 7:00 PM EDT
Filing Type: 20-F/A
Importance Score:
9
Price at Filing: $1.08
Real-time Price: $1.39 info
Change: +$0.310 (+29%) info
Market Cap: $4.734M info
BYAH
Apr 16, 2026, 7:11 AM EDT
Filing Type: F-3
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $1.39 info
Change: +$0.300 (+28%) info
Market Cap: $4.734M info
BYAH
Mar 06, 2026, 11:39 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.48
Real-time Price: $1.39 info
Change: -$0.090 (-6%) info
Market Cap: $4.734M info
BYAH
Mar 02, 2026, 6:57 AM EST
Filing Type: 20-F
Importance Score:
9
Price at Filing: $1.77
Real-time Price: $1.39 info
Change: -$0.380 (-21%) info
Market Cap: $4.734M info
BYAH
Feb 13, 2026, 4:00 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.0618
Real-time Price: $1.39 info
Change: +$1.33 (+2,149%) info
Market Cap: $4.734M info
BYAH
Feb 09, 2026, 8:52 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0937
Real-time Price: $1.39 info
Change: +$1.30 (+1,383%) info
Market Cap: $4.734M info
BYAH
Jan 28, 2026, 8:58 AM EST
Filing Type: 424B4
Importance Score:
9
Price at Filing: $0.1169
Real-time Price: $1.39 info
Change: +$1.27 (+1,089%) info
Market Cap: $4.734M info